Skip to main content
. 2020 Oct 21;21(20):7795. doi: 10.3390/ijms21207795
ANOVA Analysis of variance
BBB Blood–brain barrier
BrdU Bromodeoxyuridine
CCA Common carotid artery
CCL2 C–C motif chemokine ligand 2
CCL2-MSC Mannitol+CCL2-overexpressing hUC-MSC-treatment group
CCR2 C–C motif chemokine receptor 2
DCX Doublecortin
ECA External carotid artery
GFAP Glial fibrillary acidic protein
GFP Green fluorescent protein
hUC-MSC Human umbilical cord-derived mesenchymal stem cell
Iba-1 Ionized calcium-binding adapter molecule 1
IV Intravenous
MAN Mmannitol-treatment group
M-MSC Mannitol + hUC-MSC-treatment group
MSC Mesenchymal stem cell
MCAo Middle cerebral artery occlusion
MEM Minimum essential medium
mNSS Modified neurological severity score
NeuN Neuronal nuclei
PBS Phosphate-buffered saline
PFA Paraformaldehyde
r-tPA Recombinant tissue plasminogen activator
RECA-1 Rat endothelial cell antigen 1
RT-PCR Reverse transcription polymerase chain reaction
SEM Standard error of the mean
TTC 2:3:5-triphenyltetrazolium chloride
VEGF Vascular endothelial growth factor